nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Convolution-based approach for modeling the paliperidone extended release and Long-Acting Injectable (LAI) PK of once-, and three-monthly products administration and for optimizing the development of new LAI products
|
Gomeni, Roberto |
|
|
50 |
2 |
p. 89-96 |
artikel |
2 |
Correction to: Characterization of exposure–Clinical Dementia Rating–Sum of Boxes relationship in subjects with early Alzheimer’s disease from the aducanumab Phase 3 trials
|
Muralidharan, Kumar Kandadi |
|
|
50 |
2 |
p. 145 |
artikel |
3 |
Generative models for age, race/ethnicity, and disease state dependence of physiological determinants of drug dosing
|
Nair, Rahul |
|
|
50 |
2 |
p. 111-122 |
artikel |
4 |
Investigating the contribution of residual unexplained variability components on bias and imprecision of parameter estimates in population pharmacokinetic mixed-effects modeling
|
Jaber, Mutaz M. |
|
|
50 |
2 |
p. 123-132 |
artikel |
5 |
Latent variable indirect response modeling of clinical efficacy endpoints with combination therapy: application to guselkumab and golimumab in patients with ulcerative colitis
|
Hu, Chuanpu |
|
|
50 |
2 |
p. 133-144 |
artikel |
6 |
New Editorial Advisory Board Members and a Thank You
|
|
|
|
50 |
2 |
p. 77 |
artikel |
7 |
Population pharmacokinetic and pharmacodynamic model of propofol externally validated in Korean elderly subjects
|
Kim, Kyung Mi |
|
|
50 |
2 |
p. 97-109 |
artikel |
8 |
Two compartmental fractional derivative model with general fractional derivative
|
Miskovic-Stankovic, Vesna |
|
|
50 |
2 |
p. 79-87 |
artikel |